Stryker Corp. (NYSE:SYK) shares saw strong trading volume on Friday . 1,397,792 shares traded hands during mid-day trading, a decline of 8% from the previous session’s volume of 1,518,678 shares.The stock last traded at $121.62 and had previously closed at $122.30.

Several analysts have recently commented on the company. Zacks Investment Research raised Stryker Corp. from a “hold” rating to a “buy” rating and set a $130.00 target price for the company in a research report on Tuesday, June 21st. Guggenheim assumed coverage on Stryker Corp. in a research report on Wednesday, June 8th. They issued a “buy” rating and a $134.00 target price for the company. Sterne Agee CRT raised Stryker Corp. from a “neutral” rating to a “buy” rating and set a $130.00 target price for the company in a research report on Wednesday, April 27th. Argus raised their target price on Stryker Corp. from $120.00 to $130.00 and gave the stock a “buy” rating in a research report on Wednesday, April 27th. Finally, Brean Capital reaffirmed a “buy” rating and issued a $121.00 target price on shares of Stryker Corp. in a research report on Wednesday, April 27th. Three investment analysts have rated the stock with a sell rating, eight have assigned a hold rating and twelve have assigned a buy rating to the company. The stock has an average rating of “Hold” and an average price target of $109.23.

The firm has a market cap of $45.66 billion and a price-to-earnings ratio of 28.57. The company has a 50-day moving average price of $116.95 and a 200-day moving average price of $106.30.

Stryker Corp. (NYSE:SYK) last announced its quarterly earnings results on Wednesday, April 20th. The medical technology company reported $1.24 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.20 by $0.04. During the same period last year, the firm earned $1.11 EPS. The firm earned $2.50 billion during the quarter, compared to analyst estimates of $2.47 billion. Stryker Corp.’s quarterly revenue was up 4.9% on a year-over-year basis. Equities research analysts predict that Stryker Corp. will post $5.76 EPS for the current fiscal year.

The company also recently declared a quarterly dividend, which will be paid on Friday, July 29th. Stockholders of record on Thursday, June 30th will be issued a $0.38 dividend. This represents a $1.52 annualized dividend and a dividend yield of 1.25%. The ex-dividend date is Tuesday, June 28th.

In related news, CFO Glenn S. Boehnlein sold 2,000 shares of the company’s stock in a transaction on Wednesday, April 27th. The shares were sold at an average price of $109.61, for a total value of $219,220.00. Following the completion of the transaction, the chief financial officer now directly owns 2,509 shares of the company’s stock, valued at approximately $275,011.49. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Ronda E. Stryker sold 12,000 shares of the company’s stock in a transaction on Tuesday, April 19th. The stock was sold at an average price of $109.89, for a total transaction of $1,318,680.00. Following the completion of the transaction, the director now directly owns 193,142 shares of the company’s stock, valued at $21,224,374.38. The disclosure for this sale can be found here.

Other institutional investors recently made changes to their positions in the company. Essex Financial Services Inc. raised its position in shares of Stryker Corp. by 0.3% in the fourth quarter. Essex Financial Services Inc. now owns 11,338 shares of the medical technology company’s stock worth $1,054,000 after buying an additional 30 shares during the last quarter. Bragg Financial Advisors Inc raised its position in shares of Stryker Corp. by 0.3% in the fourth quarter. Bragg Financial Advisors Inc now owns 10,900 shares of the medical technology company’s stock worth $1,013,000 after buying an additional 35 shares during the last quarter. Brown Advisory Securities LLC raised its position in shares of Stryker Corp. by 0.8% in the fourth quarter. Brown Advisory Securities LLC now owns 12,761 shares of the medical technology company’s stock worth $1,186,000 after buying an additional 107 shares during the last quarter. LS Investment Advisors LLC raised its position in shares of Stryker Corp. by 0.8% in the fourth quarter. LS Investment Advisors LLC now owns 19,532 shares of the medical technology company’s stock worth $1,815,000 after buying an additional 154 shares during the last quarter. Finally, Harfst & Associates Inc. raised its position in shares of Stryker Corp. by 0.9% in the fourth quarter. Harfst & Associates Inc. now owns 22,750 shares of the medical technology company’s stock worth $2,114,000 after buying an additional 201 shares during the last quarter.

Stryker Corporation is a medical technology company. The Company offers a range of products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine, which help improve patient and hospital outcomes.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.